Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment

Wickström, Anne; Nyström, Josefina; Svenningsson, Anders

doi:10.1177/1352458512461391

Research article2013Peer reviewed

Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment

Wickström, Anne; Nyström, Josefina; Svenningsson, Anders

Abstract

Conclusions: Our data support the notion that early inflammatory control in MS is essential to preserve a healthy state in MS that counteracts the negative consequences of the disease both at a personal and at a societal level.

Keywords

Multiple sclerosis; work ability; biological drugs; natalizumab

Published in

Multiple Sclerosis
2013, Volume: 19, number: 5, pages: 622-630
Publisher: SAGE PUBLICATIONS LTD

SLU Authors

Nyström, Josefina
- Department of Forest Biomaterials and Technology, Swedish University of Agricultural Sciences

Sustainable Development Goals

SDG8 Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all

UKÄ Subject classification

Neurosciences
Neurology

Publication identifier

DOI: https://doi.org/10.1177/1352458512461391

Permanent link to this page (URI)

https://res.slu.se/id/publ/53989